AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
AI startup BioinvestGPT predicted the failure of Novartis AG’s ($NVS) experimental muscular dystrophy drug months before a disappointing Phase 3 re...
Takeda Pharmaceutical Co Ltd (TAK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 45,310 | $824,193 | +20% | 0% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.54 | 34,535 | $640,278.90 | 191,522 | 2026-09-14 | Filing | |
| $18.49 | 116,191 | $2,148,371.59 | 145,465 | 2026-09-02 | Filing | |
| $18.49 | 19,651 | $363,346.99 | 261,656 | 2026-08-19 | Filing | |
| $18.11 | 12,980 | $235,118.42 | 40,049 | 2026-08-18 | Filing | |
| $17.10 | 14,006 | $239,502.60 | 116,177 | 2026-08-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 761,694 | $13,855,214 | 0.18% | |
| 2. | 564,472 | $10,267,746 | 1.01% | |
| 3. | 289,107 | $5,258,852 | 0.01% | |
| 4. | 233,245 | $4,242,727 | 1.03% | |
| 5. | 180,092 | $3,275,880 | 0.03% |
News See All
Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?
Takeda Pharmaceutical Company Limited (NYSE:TAK) announced on September 14 that the FDA accepted its New Drug Application for zasocitinib under priority review for adults with moderate-to-severe plaque...
Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?
On July 30, Keros Therapeutics, Inc. (NASDAQ:KROS) triggered a $20 million development milestone payment from its global partner Takeda Pharmaceutical Company Limited (NYSE:TAK).
Is Takeda Pharmaceutical Company Limited (TAK) Stock Positioned for Growth After Strong LATITUDE Atlas Study Data?
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best low-priced pharma stocks on this list.
12 Best Low-Priced Pharma Stocks to Buy Right Now
In this article, we will be taking a look at the 12 Best Low-Priced Pharma Stocks to Buy Right Now.
Is Takeda Pharmaceutical Company Limited (TAK) Facing Major Legal Risk After U.S. Jury Rules on Generic Drug Delay?
We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds. Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best immunology stocks on our list.
8 Best Immunology Stocks to Buy According to Hedge Funds
In this article, we will be taking a look at the 8 Best Immunology Stocks to Buy According to Hedge Funds.
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2026 Earnings Call Transcript
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2026 Earnings Call Transcript May 13, 2026Takeda Pharmaceutical Company Limited beats earnings expectations.
11 Best Japanese Stocks to Buy Right Now
In this article, we will look at the 11 Best Japanese Stocks to Buy Right Now. Japanese equities have held steady amid heightened volatility in global markets.
10 Stocks to Buy on a Pullback
In this article, we will look at the 10 Stocks to Buy on a Pullback. Pullbacks tend to create favorable setups when they hit more than just the weakest parts of the market.
Hedge Fund Resource Center